InMed Pharmaceuticals (INM) EPS (Basic) (2019 - 2026)
InMed Pharmaceuticals (INM) reported EPS (Basic) of -$0.73 for Q1 2026, up 61.38% on a YoY basis from -$0.45 in Q1 2025, and down 43.14% quarter-over-quarter from -$0.51 in Q4 2025.
InMed Pharmaceuticals (INM) EPS (Basic) (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported EPS (Basic) for 8 years, with the latest figure at -$0.73 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 61.38% year-over-year to -$0.73; the trailing twelve-month figure through Mar 2026 stood at -$1.51 (up 87.31% YoY), and the FY2025 full-year result was -$8.36, up 58.49% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.73, down from -$0.51 in the prior quarter.
- The five-year high for EPS (Basic) was $0.28 in Q2 2023, with the low at -$15.24 in Q3 2023.
- Historically, EPS (Basic) has averaged -$3.55 across 5 years, with a median of -$2.71 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) sank 1407.14% — and 2025, when it jumped 104.64%.
- InMed Pharmaceuticals' EPS (Basic) stood at -$0.91 in 2022, then slumped by 307.69% to -$3.71 in 2023, then climbed by 1.89% to -$3.64 in 2024, then jumped by 85.99% to -$0.51 in 2025, then sank by 43.14% to -$0.73 in 2026.
- The last three EPS (Basic) figures came in at -$0.73 (Q1 2026), -$0.51 (Q4 2025), and -$0.44 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.83 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | -0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.73 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | -1.89 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -3.66 |
| Mar 31, 2024 | -3.58 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | -15.24 |
| Jun 30, 2023 | 0.28 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -0.91 |
| Sep 30, 2022 | -4.06 |
| Jun 30, 2022 | -13.04 |
| Mar 31, 2022 | -6.14 |
| Dec 31, 2021 | -7.73 |
| Sep 30, 2021 | -6.17 |
| Jun 30, 2021 | -36.85 |